Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy
Hybrid nanocarriers have realized a growing interest in drug delivery research because of the potential of being able to treat, manage or cure diseases that previously had limited therapy or cure. Cancer is currently considered the second leading cause of death globally. This makes cancer therapy a...
Saved in:
| Main Authors: | Joan Onyebuchi Erebor, Elizabeth Oladoyin Agboluaje, Ava M. Perkins, Megha Krishnakumar, Ndidi Ngwuluka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2024-10-01
|
| Series: | Advanced Pharmaceutical Bulletin |
| Subjects: | |
| Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-14-558.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing nature: plant-derived nanocarriers for targeted drug delivery in cancer therapy
by: Esther Ugo Alum, et al.
Published: (2025-08-01) -
Breaking barriers: targeted delivery of resveratrol in lung cancer using folate-integrated and pH-responsive hybrid nanocarriers
by: Sanjoy Das, et al.
Published: (2025-07-01) -
Next-Generation Drug Delivery for Neurotherapeutics: The Promise of Stimuli-Triggered Nanocarriers
by: Radka Boyuklieva, et al.
Published: (2025-06-01) -
Nanocarrier-based insulin delivery: A leap towards a needle-free future
by: Saranya Balasubramaniyam, et al.
Published: (2025-12-01) -
Zein-Based Nanocarriers: Advances in Oral Drug Delivery
by: Yuxin Liu, et al.
Published: (2025-07-01)